Your Guide to Immunohistology | Celnovte Biotechnology

SHOP

Home
Product
- IMMUNOHISTOCHEMISTRY
- INSTRUMENT
- MOLECULAR
  - CISH
  - SUPER-ISH™
  - FISH
  - CONSUMABLES
- HISTOLOGY
  - H&E STAINS
  - SPECIAL STAINS
- CYTOLOGY
- DIGITAL PATHOLOGY
  - DIGITAL SCANNER
Solution
Support
About
Contact
- U.S.A
- CHINA

Home

Solution

BLOG

Solution

Understanding ER-Positive Breast Cancer: What You Need to Know

Understanding ER-Positive Breast Cancer: What You Need to Know

Hormone therapy stands as a cornerstone treatment for ER-positive breast cancer.

Super-ISH™：Albumin mRNA in-situ Hybridization Assists in the Diagnosis of Hepatocellular Carcinoma

Super-ISH™：Albumin mRNA in-situ Hybridization Assists in the Diagnosis of Hepatocellular Carcinoma

Tumors metastasizing to the liver from other organs: The liver is the largest solid organ in the human body and is the most common site of metastasis for most malignant tumors, especially gastrointestinal and pancreatic malignancies.

PD-L1: An important biomarker for companion diagnostics

PD-L1: An important biomarker for companion diagnostics

Programmed death-ligand 1 (PD-L1, also known as B7-H1) is a ligand for PD-1 and belongs to the B7 superfamily.

Surprising Facts About HER2 and Its Role in Cancer Treatment

Surprising Facts About HER2 and Its Role in Cancer Treatment

HER2, or Human Epidermal Growth Factor Receptor 2, is a protein that plays a role in the growth and division of cells.

Immunohistochemistry Stainer Insights: What Makes the CNT 360 Stand Out

Immunohistochemistry Stainer Insights: What Makes the CNT 360 Stand Out

Immunohistochemistry stainers are very important tools in clinical diagnosis for finding different kinds of cancer.

Recommendation of antibodies: TROP2-immunohistochemistry

Recommendation of antibodies: TROP2-immunohistochemistry

Recommendation of antibodies: 2023 CSCO guidelines add detection target Claudin18.2.

Recommendation of antibodies: 2023 CSCO guidelines add detection target Claudin18.2.

Claudin18.2 protein, with its high expression rate in gastric and pancreatic cancer tumors, holds great promise as an ideal target.

Why is Kappa/lambda In-situ Hybridization Critically Acclaimed?

Why is Kappa/lambda In-situ Hybridization Critically Acclaimed?

Cervical Cancer Screening with Cytology Dual Staining of P16/Ki-67 by Celnovte

Cervical Cancer Screening with Cytology Dual Staining of P16/Ki-67 by Celnovte

Approximately 300 million eligible women aged 35 to 64 in China need to undergo cervical cancer screening.